The conservation and banking of tissues subsequent to donor harvest is an extended medicinal area that has until lately witnessed progress. Nevertheless, in a similar way we bank stem cells, embryos and other tissues at present are likely to govern the biological time for complete tissues through approaches identical to vitrification and controlled hypothermia. A constant growth of tissues and organs scarcity has led to early deaths with consequences in enormous outlays to society. The capacity to bank tissues has an instantaneous effect on transplant medicine, surgical treatment of cancer, combat trauma, and industrial accidents.

Market Analysis - The “Global Tissue Banking Market” is estimated to witness a CAGR of 11.2% during the forecast period 2018–2024. The market is analyzed based on four segments – type, application, tissue type, and regions.

Regional Analysis - The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). North America accounts for the largest share of the tissue banking market, followed by Europe, Asia Pacific, and Rest of the World. More than 44.0% of the market is occupied by North America, with the US being the major contributor to the market growth.

Type Analysis - Based on types, the market is segmented into equipment and consumables. Equipment holds a dominant share in the market and is also the fastest growing segment.

Application Analysis - Based on application areas, the market is segmented into clinical application and research & development. The market is dominated by research & development.

Tissue Type Analysis - Based on tissue banking areas, the market is segmented into cardiovascular tissue, lung tissue, kidney tissue, corneal tissue, and other tissues. The corneal tissue segment is dominant among others in the market.

Key Players - The major players in the market are Thermo Fisher Scientific, Danaher Corporation, Custom Biogenic Solution, Tecan Group, and Brooks Automation, Inc.

Competitive Analysis - The tissue banking market is facing intense competition due to the presence of many players in the market. However, the majority of the market share is occupied by Thermo Fisher Scientific, Danaher Corporation, Custom Biogenic Solution, Tecan Group, and Brooks Automation, Inc. To maintain their leadership, the major players are collaborating with small players who have advanced technology. For instance, in March 2014, Brooks Automation collaborated with BioCision for the development of automated temperature-controlled technology for biobanking and sample handling. This association helped in filling the gap amongst sample handling and automation process.

Benefits - The report provides complete details about the usage and adoption rate of tissue banking in various regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in specific verticals to analyze before investing or expanding the business in this market.

Key Stakeholders 

1     Industry Outlook 

1.1        Industry Overview

1.2        Total Addressable Market (TAM)

1.3        Trends of the Market

2     Report Outline 

2.1        Report Scope

2.2        Report Summary

2.3        Research Methodology

2.4        Report Assumptions

3     Market Snapshot

3.1        Market Definition – Infoholic Research

3.2        Segmented Addressable Market (SAM)

3.3        Industry Trends

3.4        Related Markets

3.4.1     Wound Biologics

3.4.1.1  Trends in Wound Biologics Market

3.4.2     Stem Cell Banking

3.4.2.1    Trends in Stem Cell Banking Market

4     Market Outlook 

4.1        Evolution

4.2        Market Segmentation

4.3        Porter 5 (Five) Forces

5     Market Characteristics

5.1        Market Dynamics

5.1.1     Drivers

5.1.1.1    Increasing demand for regenerative medicine

5.1.1.2    Advancements in Tissue Banking Technologies

5.1.2     Restraints

5.1.2.1    Stringent regulatory requirement

5.1.2.2    Ethical Issues

5.1.3     Opportunities

5.1.3.1    Market opportunities in Asia Pacific

5.1.3.2    Mergers and acquisitions

5.1.4     DRO – Impact Analysis

6     Types: Market Size and Analysis

6.1        Overview

6.2        Tissue Banking Equipment

6.3        Accessories and Consumables

7     Application: Market Size and Analysis

7.1        Overview

7.2        Clinical Application

7.3        Research and Development

8     Types: Market Size and Analysis

8.1        Overview

8.2        Cardiovascular Tissue

8.3        Corneal Tissue

8.4        Lungs Tissue

8.5        Kidney Tissue

8.6        Others Tissue

9     Regions: Market Size and Analysis

9.1        Overview

9.2        North America

9.2.1     Overview

9.2.2     US  39

9.2.3     Canada

9.3        Europe

9.3.1     Overview

9.3.2     UK  41

9.3.3     Germany

9.4        Asia Pacific

9.4.1     Overview

9.4.2     India

9.4.3     China

9.4.4     Japan

9.5        Rest of the World

9.5.1     Overview

9.5.2     Brazil

10   Competitive Landscape 

11   Vendors Profile 

11.1     Thermo Fisher Scientific, Inc.

11.1.1  Overview

11.1.2  Business Units

11.1.3  Geographic Presence

11.1.4  Business focus

11.1.5  SWOT analysis

11.1.6  Business Strategy

11.2     Danaher Corporation

11.2.1  Overview

11.2.2  Business Units

11.2.3  Geographic Revenue

11.2.4  Business Focus

11.2.5  SWOT Analysis

11.2.6  Business Strategies

11.3     Custom Biogenic Systems Inc

11.3.1  Overview

11.3.2  Business Focus

11.3.3  SWOT Analysis

11.3.4  Business Strategies

11.4     Brooks Automation, Inc.

11.4.1  Overview

11.4.2  Business Units

11.4.3  Geographic Presence

11.4.4  Business Focus

11.4.5  SWOT Analysis

11.4.6  Business Strategies

11.5     Tecan Group

11.5.1  Overview

11.5.2  Business Units

11.5.3  Geographic Presence

11.5.4  Business Focus

11.5.5  SWOT Analysis

11.5.6  Business Strategies

12   Companies to Watch for

12.1     Biolife Solutions

12.1.1  Overview

12.2     VWR Corporation

12.2.1  Overview

12.3     PHC Holdings Corporation

12.3.1  Overview

12.3.2  Key Highlights

12.4     Bluechiip Limited

12.4.1  Overview

12.5     Merck KGaA

12.5.1  Overview

12.6     Eppendorf AG

12.6.1  Overview

Annexure 

Ø           Acronyms